Story perspectives

U.S. Pressures China, Fears Shift of Drug Production to India

12/5/2025

36 5

Summary

Story summary

The United States pressured China to regulate its chemical industry after concerns that chemical exports to Mexican cartels fuel fentanyl production, resulting in restrictions on 13 chemicals.
In 2022, the U.S. Opioid Commission warned that India is a significant supplier of drug precursors, with extensive illicit production and weaker drug policy controls than China.
Those findings raise fears that illegal drug production could shift more toward India.

1 of 1

Story summary

The United States pressured China to regulate its chemical industry after concerns that chemical exports to Mexican cartels fuel fentanyl production, resulting in restrictions on 13 chemicals.
In 2022, the U.S. Opioid Commission warned that India is a significant supplier of drug precursors, with extensive illicit production and weaker drug policy controls than China.
Those findings raise fears that illegal drug production could shift more toward India.